Board of Directors

The Genmab Board of Directors meets several times a year for ordinary or extraordinary meetings. Board duties include overseeing the business strategy, accounting practices, executive compensation, corporate governance practices and the appointment of executive officers. The Board of Directors has established four committees: the Compensation Committee, the Audit Committee, the Scientific Committee and the Nominating and Corporate Governance Committee.

In accordance with the articles of association, the Board of Directors is elected  partly by the Annual General Meeting (AGM) and partly by Genmab employees.  Board members elected by the AGM are elected for a period of one year whereas board members elected by Genmab employees are elected for a period of three years. Members may stand for re-election for successive terms. The Board of Directors shall consist of not less than three and no more than nine members; and is currently comprised of nine members including three employee representatives.

A Target Figure for the Number of Women in the Board of Directors of Genmab A/S has been established.

The business address for the members of the Board of Directors is c/o Genmab A/S, Bredgade 34E, 1260 Copenhagen K, Denmark.

BoD mp190x110_JOM Mats Pettersson, B.Sc.

Swedish, 71
Board Chairman; Chairman of the Nominating & Corporate Governance Committee, Member of the Audit Committee and Compensation Committee

BoD agp190x110 Anders Gersel Pedersen, M.D., Ph.D.

Danish, 65  
Deputy Chairman (non-independent); Chairman of the Compensation Committee, Member of the Scientific Committee 

BoD dc190x110Deirdre P. Connelly

American, 55
Board Member; Member of the Audit Committee and the Nominating & Corporate Governance Committee

BoD pe190x110 Pernille Erenbjerg

Danish, 49 
Board Member; Chairman of the Audit Committee, Member of the Nominating & Corporate Governance Committee

BoD pp190x110 Paolo Paoletti, M.D.

Italian (USA citizenship), 66
Board Member; Chairman of the Scientific Committee

BoD psk190x110 Peter Storm Kristensen

Danish, 42
Board Member (non-independent)

BoD rh190x110 Rick Hibbert, MBA, Ph.D.

British, 37
Board Member (non-independent)

BoD db190x110 Daniel J. Bruno

American, 37
Board Member (non-independent)

BoD rho190x110Rolf Hoffmann

German, 57
Board Member; Member of the Compensation Committee and the Scientific Committee